In certain patients, anti-nuclear antibody may play a role.

On anti-nuclear antibody tests, these antigens have a speckled pattern.

Of the antibodies, 90% have a detectable anti-nuclear antibody.

Anti-Jo1 antibodies are a type of anti-nuclear antibody.

Unlike in SLE, an anti-nuclear antibody test is usually negative.

Anti-nuclear antibodies appear to be prognostic agents in PBC.

The development of anti-nuclear antibodies (ANA) has been found in 10 to 30% of patients under treatment with acebutolol.

The appearance of anti-nuclear antibodies in autoimmune hepatitis was found to correlated with A1-B8-DR3.

Centromere proteins are also the autoantigenic target for some anti-nuclear antibodies, such as anti-centromere antibodies.

Since this activity occurs in the nucleus of the cell ATA is a form of anti-nuclear antibody.

A prominent humoral abnormality in SSc is manifested by the presence of anti-nuclear antibodies [ 5].

Anti-nuclear antibody (ANA)

Rheumatoid factor (RF) and anti-nuclear antibody (ANA) were negative.

Distinguishing laboratory characteristics are a positive, speckled anti-nuclear antibody and an anti-U1-RNP antibody.

These are known as anti-nuclear antibodies (ANA) and have also been observed in concert with multiple sclerosis as part of general immune system dysfunction.

These are called anti-mitochondrial antibodies (AMA) and anti-nuclear antibodies (ANA), respectively.

The kinetoplast found in C.luciliae allows them to be used for the detection of anti-dsDNA antibodies, a type of anti-nuclear antibody.

Anti-dsDNA antibodies are a group of anti-nuclear antibodies and their target antigen is double stranded DNA.

Recognized by anti-nuclear antibodies found in primary biliary cirrhosis (PBC) anti-Nup210 antibodies correlate with progression toward end stage liver disease.

Anti-nuclear antibodies are a common feature in SLE and anti-dsDNA antibodies are highly specific for the disease.

This type affects fewer than four joints (usually the large joints such as knees, ankles or wrists) and may cause eye inflammation in girls with positive anti-nuclear antibodies (ANA).

Anti-nuclear antibodies (ANAs, also known as anti-nuclear factor or ANF) are autoantibodies that bind to contents of the cell nucleus.

However, laboratory tests may also help in discovering inflammation by checking C-reactive protein level, erythrocyte sedimentation rate, level of peripheral leukocytes, ferritin level, anti-nuclear antibodies level, and rheumatoid factor status.

DQ7.6 is positively associated with asthma, pauciarticular juvenile arthritis without anti-nuclear antibodies, DQ7.6 is negatively associated (Protective against) juvenile diabetes, liver and spleen disease in Schistosoma japonicum infection, pulmonary tuberculosis.

Blood tests can be done to determine if a patient has high levels of antibodies that are indicative of the condition, such as anti-nuclear antibody (ANA) and rheumatoid factor (because SS frequently occurs secondary to rheumatoid arthritis), which are associated with autoimmune diseases.

Unlike antibodies that fight infection, antinuclear antibodies attack healthy cells.

Animal tissue was the first substrate for immunofluorescent detection of antinuclear antibodies and has been in use since the late 1950s.

Antinuclear antibodies were detected in 65/238 (27%) patients, and were of comparable prevalence in the patient groups.

These proteins are called antinuclear antibodies, or ANAs.

Antinuclear antibodies cause an inflammation in the uterus that does not allow it to be a suitable host for implantation of the embryo.

Rheumatoid factor, antinuclear antibodies, and non-organ specific antibodies may be present in the serum.

The Antinuclear antibody (ANA) test is often ordered first.

An antinuclear antibodies (ANA) test is done to help identify problems with the immune system, such as:

Assay for antinuclear antibody, extractable nuclear antigens, anticentromere antibodies, and cryoglobulins were negative.

ANA (antinuclear antibodies), to check for lupus (systemic lupus erythematosus).

Prolonged use of procainamide may frequently cause the body to make certain immune molecules (antinuclear antibodies) that may make you ill.

Both the presence of anti-phospholipids antibodies and antinuclear antibodies have toxic effects on the implantation of embryos.

Sera from patients positive for antinuclear antibodies were also excluded (15% in ulcerative colitis; 8.5% in Crohn's disease).

Antinuclear antibodies (ANA).

The association with viral hepatitis was subsequently demonstrated and patients with antinuclear antibodies were more likely to have A1-B8-DR3.

An antinuclear antibody (ANA) test measures the amount and pattern of antibodies in your blood that work against your own body (autoimmune reaction).

Monocytes, one type of leukocyte, detect the antigen and relay the recognition to T helper cells, creating antinuclear antibodies leading to an immune response.

The first evidence for antinuclear antibodies arose in 1948 when Hargraves, Richmond and Morton discovered the LE cell.

Some immunological reasons that contribute to infertility are reproductive autoimmune failure syndrome, the presence of anti-phospholipid antibodies, and antinuclear antibodies.

There are autoantibodies (particulate stratified squamous-epithelium-specific antinuclear antibody) shown when the lesion is biopsied and immunofluorescence is carried out.

Antinuclear antibodies and anti-smooth muscle antibody are found in 20%-50% of PSC patients and, likewise, are not specific for the disease.

Some children with pauciarticular JRA have abnormal proteins in the blood called antinuclear antibodies (ANAs).

An individual that presents with reproductive autoimmune failure syndrome has unexplained infertility, endometriosis, and repetitive miscarriages due to elevated levels of antinuclear antibodies circulating.

Other Autoantibodies Antinuclear antibody (ANA) titer was determined by indirect immunofluorescence using Hep-2 substrate.

In contrast to one previous study, however [ 21 ] , we did not find a significantly higher prevalence of antinuclear antibodies in women with premature ovarian failure.